undefined Stock News
GuruFocus News Biotechnology
Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Global Expansion
Catalyst Pharmaceuticals Inc (CPRX) reports a 25.3% increase in total revenue and updates its full-year guidance, while navigating competitive challenges and global market opportunities. Nov 10, 2024